As the summer holiday season begins to draw to a close, teams across the medical device industry are gradually returning to their usual routines.
At MDS, the summer months have remained active. While project schedules may look different during the holiday period, quality and regulatory responsibilities continue throughout the product lifecycle. Documentation still needs to be maintained, post-market activities need to stay current, submissions move forward, and quality systems continue to evolve.
This summer’s work has once again reflected the breadth of practical QA/RA support that medical device companies may need at different stages of development and market presence.
Strengthening quality systems and processes
A quality management system is never truly finished.
As companies grow, products mature, and regulatory expectations develop, procedures and responsibilities need to be reviewed and updated. Over the summer, our work has included quality manual and QMS updates, the creation of supporting documentation such as competence matrices, and reviews of whether existing processes meet current regulatory needs.
Audit and CAPA processes have also been an important part of this work. This has included reviewing audit practices, refining SOPs, strengthening root cause analysis guidance, and assessing how corrective and preventive actions are managed in practice.
These activities may appear separate, but they all contribute to the same goal: ensuring that the quality system reflects how the organisation actually works and provides a reliable structure for continued compliance.
Keeping clinical and post-market documentation current
Clinical and post-market documentation requires regular attention after a device reaches the market.
During the summer, our support has included updates to Periodic Safety Update Reports, Clinical Evaluation Reports, literature search plans, and medical device files. Work has also covered CAPA and adverse event information used in PSUR activities, as well as improvements to the analysis and presentation of MAUDE search results.
Another important task has been reviewing consistency between clinical documentation and public product information. Claims made on websites and in marketing materials should remain supported by the available clinical evidence and the intended use of the device.
This kind of cross-checking can help identify inconsistencies before they become larger regulatory or compliance questions.
Supporting PMS and regulatory documentation
Post-market surveillance is an ongoing process rather than a single reporting task.
Our summer work has included creating MDR-aligned PMS Plan and PMS Report templates, reviewing existing documentation, and supporting updates needed to keep post-market processes structured and current.
The same principle applies across technical documentation. Small changes, forced reviews, updated responsibilities, and revised regulatory expectations can all create a need to revisit existing files.
Maintaining this documentation continuously is generally more manageable than allowing updates to accumulate until the next audit, notified body review, or regulatory deadline.
Moving clinical investigations and submissions forward
Regulatory submissions and clinical investigation activities also continue during the summer.
Recent work has included reviewing and cleaning documentation for a clinical investigation application, checking revised materials after multiple feedback rounds, confirming that essential information was included, and supporting the completion of the application itself.
FDA-related work has included preparation of electronic submission materials, classification and labelling considerations, and coordination between the different parties involved in the process.
These projects demonstrate why regulatory support often requires more than reviewing a final document. It can involve coordinating information, identifying missing elements, improving the structure of the submission, and helping ensure that the different parts of the project remain aligned.
Supporting the full product lifecycle
The variety of work completed over the summer reflects the reality of QA/RA support.
A company may need assistance with a broad QMS update, an internal audit process, or a major regulatory submission. It may also need targeted help with a specific PSUR section, batch release documentation, a clinical evidence review, or a single procedure that no longer reflects current practice.
Not every need requires a large project. In many cases, focused specialist support can help an internal team complete a defined task, confirm that documentation is consistent, or bring an independent view to an area that has become difficult to assess internally.
The common thread is practical support that fits the company’s current situation.
Moving into the autumn
As organisations return from the summer holiday period, many will begin preparing for autumn audits, documentation deadlines, regulatory submissions, and the next stages of product development.
This is a useful time to review what has accumulated during the summer, identify priorities, and confirm that quality and regulatory activities remain on track.
Whether the need is a focused documentation review, post-market support, an audit, QMS development, clinical work, or broader regulatory guidance, MDS works alongside internal teams to provide additional expertise and capacity where it is most useful.
If your organisation is returning to a busy QA/RA schedule after the summer, MDS can help review priorities, strengthen documentation, and move ongoing work forward.
You can contact us at sales@mdsfinland.com or via Book a Meeting.
